34 results
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
17 Apr 24
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
6:43am
and the Extracorporeal Membrane Oxygenation program at the Department of Cardiothoracic Surgery at Beilinson Hospital, stated: “As physicians, our foremost
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Apr 24
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
8:46am
to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).
(ll) U.S. Real Property Holding
6-K
EX-10.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
27 Dec 23
Inspira Announces $3.88 Million Registered Direct Offering
4:46pm
of the U.S. Treasury Department (“OFAC”).
(ll) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
11 Dec 23
In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil to Medical Advisory Board
9:29am
Intensive Care Unit and the Extracorporeal Membrane Oxygenation program at the Department of Cardiothoracic Surgery at Rabin Medical Center, Israel. Dr
6-K
EX-99.1
9q8364tu39y4o4qq
16 Nov 23
Inspira™ Technologies Reports Third Quarter 2023 Financial Results
9:27am
6-K
EX-99.2
yyqm95zzo xy0zw4t
2 Oct 23
Interim Condensed Financial Statements
4:01pm
6-K
EX-99.1
5vyh330rthod8qhpof1z
10 Aug 23
Inspira™ Technologies Reports Second Quarter 2023 Financial Results
9:21am
6-K
EX-99.1
fvhieh hm2y
18 May 23
Inspira™ Technologies Reports First Quarter 2023 Financial Results
4:01pm
6-K
EX-1.1
0w2vn
4 Apr 23
Report of Foreign Private Issuer
4:21pm
6-K
EX-99.1
e58rjif
14 Dec 22
Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLATM Blood Sensor
8:52am
20-F
l9mq17c
31 Mar 22
Annual report (foreign)
4:48pm
6-K
EX-99.1
d1dm0cs6pz9j4 3nbp
3 Feb 22
Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO) - Daniella Yeheskely-Hayon PhD
9:06am
POS AM
jfp5hq ppz97wt2fpd9
27 Oct 21
Prospectus update (post-effective amendment)
9:17am
6-K
EX-99.1
gkut0jqpj27qa4z72zj
19 Jul 21
Inspira Technologies and Ben-Gurion University Have Developed a
9:07am
6-K
EX-99.1
5ot6r6b leikn
16 Jul 21
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
3:26pm
424B4
7oais 6cmx4qout552
15 Jul 21
Prospectus supplement with pricing info
4:06pm
6-K
EX-99.1
5cth5r1hwp98voc8
14 Jul 21
Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
6:08am
F-1/A
h3zn5 aycvyqtstmk
1 Jul 21
Registration statement (foreign) (amended)
11:58am